Resveratrol: Properties, Sources, Production and Their Medical Applications A Review

Authors

  • Anaheed H. Hameed Biotechnology Division, Applied Science Department ,University of Technology
  • Shemaa A. Soud Biotechnology Division,Applied Science Department ,University of Technology
  • Maysaa A. Ali Biotechnology Division, Applied Science Department ,University of Technology

Keywords:

Resveratol,, Polyphenol, Therapeutic substance, Phytoalexin, Antioxidant.

Abstract

Background:

Resveratrol(RVS) was described at first by Takaoka in 1939 as a bioactive part in the Veratrum grandiflorum plant roots.

Materials and Methods:

RVS a (3,5,4′-trihydroxy-trans-stilbene) a natural phenols which were founded in over than seventy plants, especially in grapes' skins and seeds, red wines and other human nourishments. The double bond of RSV has been  synthesized by a Wittig condensation. While, bioproduction is launched from phenylpropanoid acid having cinnamic and 4-coumaric acids which were derived from amino acids. RSV over and over deferred the rate of infections, for example, atherosclerosis, cardiovascular sickness, diabetes type 2, malignancy and neurodegenerative illnesses.

Results:

Most of the studies dealt with RSV as an antioxidant and treatment for oxidative damage that causes damage in vivo, such as diabetes, neurodegeneration, heart disease, cancer and aging. RSV is several known for its powerful scavenging efficiency.

Conclusion:

In this research, sources,production and features of RSV are included as well as the previous data that was reviewed that dealt with the use of RSV as a therapeutic substance for managing aging skin, cancer treatment, diabetes, blood pressure and brain support

Downloads

Download data is not yet available.

Published

2021-07-01

How to Cite

[1]
A. H. . Hameed, S. A. . Soud, and M. A. . Ali, “Resveratrol: Properties, Sources, Production and Their Medical Applications A Review”, JUBPAS, vol. 29, no. 2, pp. 45-66, Jul. 2021.

Issue

Section

Articles